Targeting one‐carbon metabolism for cancer immunotherapy
Clinical and Translational Medicine · 2024-01 · 14 (1)
DOI: 10.1002/ctm2.1521 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 27.01.2024. Verfasst von Xinxin Ren und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, Otolaryngology & Head and Neck Center, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's…. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Key projects jointly constructed by the Ministry and the province of Zhejiang Medical and Health Science and Technology Project.
Abstract (Originalsprache)
Background
One‐carbon (1C) metabolism is a metabolic network that plays essential roles in biological reactions. In 1C metabolism, a series of nutrients are used to fuel metabolic pathways, including nucleotide metabolism, amino acid metabolism, cellular redox defence and epigenetic maintenance. At present, 1C metabolism is considered the hallmark of cancer. The 1C units obtained from the metabolic pathways increase the proliferation rate of cancer cells. In addition, anticancer drugs, such as methotrexate, which target 1C metabolism, have long been used in the clinic. In terms of immunotherapy, 1C metabolism has been used to explore biomarkers connected with immunotherapy response and immune‐related adverse events in patients.
Methods
We collected numerous literatures to explain the roles of one‐carbon metabolism in cancer immunotherapy.
Results
In this review, we focus on the important pathways in 1C metabolism and the function of 1C metabolism enzymes in cancer immunotherapy. Then, we summarise the inhibitors acting on 1C metabolism and their potential application on cancer immunotherapy. Finally, we provide a viewpoint and conclusion regarding the opportunities and challenges of targeting 1C metabolism for cancer immunotherapy in clinical practicability in the future.
Conclusion
Targeting one‐carbon metabolism is useful for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Head and Neck Surgery, Otolaryngology & Head and Neck Center, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
- Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, China.
- Zhejiang Provincial Clinical Research Center for Malignant Tumor, Hangzhou, Zhejiang, China.
- Department of Pathology, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
- Department of Pharmacy, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Pharmacy, Center for Clinical Pharmacy, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
ORCID-Profile: Minghua Ge
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Key projects jointly constructed by the Ministry and the province of Zhejiang Medical and Health Science and Technology Project
- Medical and Health research project of Zhejiang province
- Traditional Chinese Medicine Science and Technology Project of Zhejiang Province
- Key Research and Development Program of Zhejiang Province
- Seed Foundation of Zhejiang Provincial People's Hospital
Zitieren
APA
Ren, X., Wang, X., Zheng, G., Wang, S., Wang, Q., Yuan, M., Xu, T., Xu, J., Huang, P., & Ge, M. (2024). Targeting one‐carbon metabolism for cancer immunotherapy. Clinical and Translational Medicine, 14(1). https://doi.org/10.1002/ctm2.1521
Vancouver
Ren X, Wang X, Zheng G, Wang S, Wang Q, Yuan M, et al. Targeting one‐carbon metabolism for cancer immunotherapy. Clinical and Translational Medicine. 2024;14(1). doi:10.1002/ctm2.1521
BibTeX
@article{Ren2024,
author = {Ren, Xinxin and Wang, Xiang and Zheng, Guowan and Wang, Shanshan and Wang, Qiyue and Yuan, Mengnan and Xu, Tong and Xu, Jiajie and Huang, Ping and Ge, Minghua},
title = {Targeting one‐carbon metabolism for cancer immunotherapy},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {1},
doi = {10.1002/ctm2.1521}
}
EUVIMED